BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1143260)

  • 1. Serum acid phosphatase levels in untreated carcinoma patients.
    Ho E; Mehan DJ
    Mo Med; 1975 Jun; 72(6):289-90. PubMed ID: 1143260
    [No Abstract]   [Full Text] [Related]  

  • 2. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH; Bauer HW; Dati F
    Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
    Breitwieser P; Nöske HD
    Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.
    Little C; Shojania AM; Green PT; Weinerman BH
    Can Med Assoc J; 1978 Aug; 119(3):259-61. PubMed ID: 679131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic acid phosphatase: a look and world of caution.
    Ablin RJ
    Allergol Immunopathol (Madr); 1981; 9(4):357-8. PubMed ID: 7304374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostatic acid phosphatase by enzymeimmunoassay].
    Masukagami T; Ando K; Shimazaki J
    Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J; Lorente JA; Reig C; López Pacios MA; de Torres JA; Soler Roselló A
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What clinical information is wanted from measurements of tumor markers in carcinoma of the prostate?
    Andersson L
    Scand J Clin Lab Invest Suppl; 1985; 179():107-14. PubMed ID: 3866303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1484-8. PubMed ID: 6164809
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous measurement of acid phosphatase activity in bone marrow and peripheral blood serum.
    Catane R; Wajsman Z; Chu TM; Saroff J; Mittelman AA; Murphy GP
    Surg Forum; 1977; 28():128-30. PubMed ID: 617393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Errors in the determination of acid phosphatases in serum].
    Ziesche HW
    Zentralbl Chir; 1967 Aug; 92(31):2317-21. PubMed ID: 5596663
    [No Abstract]   [Full Text] [Related]  

  • 16. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
    Lewenhaupt A; Ekman P; Eneroth P; Eriksson A; Nordström L
    Scand J Clin Lab Invest Suppl; 1985; 179():75-80. PubMed ID: 3878574
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical application of immunodiffusion assay for prostatic acid phosphatase.
    Moncure CW
    Natl Cancer Inst Monogr; 1978 Dec; (49):241-2. PubMed ID: 107456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of serum prostatic acid phosphatase in prostatic carcinoma. A comparative study with an enzymatic assay.
    Ishibe T
    Acta Urol Belg; 1981 Jan; 49(1):64-72. PubMed ID: 6163343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.